New pen for insulin gets green light
Long-acting Lantus (insulin glargine, Sanofi-Aventis) will soon be available in a device that will allow diabetes patients to administer up to 80 units in one injection.
Long-acting Lantus (insulin glargine, Sanofi-Aventis) will soon be available in a device that will allow patients to administer up to 80 units in one injection. Lantus SoloStar is a disposable, prefilled insulin pen that allows patients to dial their dose, up to 80 units. The product should be stored between 36° and 46°F until first use, after which it may be kept at room temperature, as long as it remains below 77°F. Once opened, the pen can be used for up to 28 days. Insulin glargine is indicated for once-daily treatment of hyperglycemia in patients with Type 1 or Type 2 diabetes. According to the manufacturer, Lantus SoloStar will be available in pharmacies sometime in 2007.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
